Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patient willing to give consent for the study. Clinically diagnosed cases of allergic rhinitis. Patients of all genders. Patient of adult age group.
Exclusion criteria
Exclusion criteria: Patients with complications of allergic rhinitis like asthma, hyperpyrexia. patient taken any line of treatment in the past 1 month or during study. Pregnant and lactating women. Patients with suspected immuno-compromised disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcome assessment will be done by applying mini rhinoconjunctivitis quality of life questionnaire Minirqlq consist of five domains with a total of 14 questions 2 questions for practical problems 3 questions each for activity limitations nose eye and other symptoms score indicating from 0 to 6 for each question 0 not troubled 1 rarely troubled 2 somewhat troubled 3 moderately troubled 4 quite a bit troubled 5 very troubled 6 extremely troubled Total score for allergic rhinitis calculated by total mean of all 5 domains of minirqlq Improvement will be calculated on the basis of total score of all 5 domains Improved after total score lower than before baseline Not improved no change in total score before baseline and after treatment Worse after total score is higher than before baseline treatment Timepoint: Duration of study is 18 months. Duration of each case is each case will be studied for 6 months or till remission occur, whichever is earlier. Duration of follow up is each case will be followed up on every 15th day or as required. Clinical assessment will be done at baseline, 3rd month and at the end of treatment or at 6th month whichever is earlier | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Dr G D Pol Foundation Y M T Homoeopathic Medical College And P G Institute Hospital